Molecular profiling and access to treatment for rare cancers in Europe – ARCAGEN study final results
Final results of ARCAGEN – an EORTC-SPECTA and EURACAN initiative [...]
New study advances personalised medicine for rare Peritoneal Mesothelioma
Brussels, Belgium, 15 July 2026. A recent study published [...]
2148 MRD Study reaches milestone with First Patient In (FPI)
Minimal Residual Disease Assessment (MRD): New study explores whether a [...]
IMMUcan has completed patient enrolment
We are thrilled to announce that as of October 30th, [...]
Happy 2 year anniversary BioRadon!
Radon, a radioactive gas that can accumulate inside homes, is [...]
IMMUcan reaches 1500 Patients enrolled
The IMMUcan project has successfully reached a major milestone by [...]
300 Patients Registered for the Bioradon Study
The EORTC 1920 BIORADON team is pleased to announce that [...]
2000 Patients Enrolled on the SPECTA Platform
We are thrilled to announce that a major milestone was [...]
Arcagen project recruitment is now complete
We are happy to announce that we finished patient recruitment [...]
EORTC and Alliance Healthcare’s continued partnership
Brussels, May 19, 2022 – The European Organisation for Research [...]
